GlassScriptPhysician profile
Scott A Watkins
NPI 1417905332
$5,070.03
in general payments reported to CMS, 2019-2025
42 companies · $994 in 2025
The $994 reported for 2025 was more than what 85% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $680 · 2020: $327 · 2021: $792 · 2022: $607 · 2023: $849 · 2024: $821 · 2025: $994.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,664.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,663.77 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,376.05 | 2019-2025 | Vraylar, Ubrelvy, Qulipta |
| Novo Nordisk INC | $377.26 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Pfizer INC. | $345.70 | 2019-2025 | |
| Lilly USA, LLC | $319.50 | 2019-2025 | Mounjaro, Zepbound, Jardiance |
| Astrazeneca Pharmaceuticals LP | $288.59 | 2019-2025 | Farxiga, Airsupra, Breztri |
| Amgen INC. | $270.49 | 2019-2025 | Evenity, Prolia, Repatha |
| Glaxosmithkline, LLC. | $202.86 | 2022-2025 | Shingrix, Arexvy, Bexsero |
| Allergan, INC. | $180.74 | 2019-2020 | |
| Amarin Pharma, INC. | $166.22 | 2019-2022 | |
| Corium, LLC | $145.56 | 2022-2025 | Azstarys |
| Lundbeck LLC | $110.98 | 2021-2024 | Vyepti |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $92.50 | 2019-2023 | Xifaxan |
| Novartis Pharmaceuticals Corporation | $87.72 | 2019-2024 | |
| Merck Sharp & Dohme LLC | $81.37 | 2019-2024 | Gardasil 9, Vaxelis, Vaxneuvance |
| Astellas Pharma US INC | $78.34 | 2019-2025 | Veozah |
Show all 42 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Scott Watkins listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.